Aortic aneurysms: current pathogenesis and therapeutic targets

被引:15
|
作者
Cho, Min Ji [1 ]
Lee, Mi-Ran [2 ]
Park, Jong-Gil [1 ,3 ]
机构
[1] Korea Res Inst Biosci & Biotechnol KRIBB, Biotherapeut Translat Res Ctr, 125 Gwahak Ro, Daejeon 34141, South Korea
[2] Jungwon Univ, Dept Biomed Lab Sci, 85 Munmu Ro, Chungbuk 28024, South Korea
[3] Korea Univ Sci & Technol UST, KRIBB Sch Biosci, Dept Biosci, 125 Gwahak Ro, Daejeon 34141, South Korea
来源
EXPERIMENTAL AND MOLECULAR MEDICINE | 2023年 / 55卷 / 12期
基金
新加坡国家研究基金会;
关键词
PERIARTERIAL APPLICATION; OXIDATIVE STRESS; INTERFERON-GAMMA; MARFAN-SYNDROME; MUTATIONS; DISSECTIONS; ACTIVATION; EXPRESSION; PROTEIN; ANGIOGENESIS;
D O I
10.1038/s12276-023-01130-w
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Aortic aneurysm is a chronic disease characterized by localized expansion of the aorta, including the ascending aorta, arch, descending aorta, and abdominal aorta. Although aortic aneurysms are generally asymptomatic, they can threaten human health by sudden death due to aortic rupture. Aortic aneurysms are estimated to lead to 150,000 similar to 200,000 deaths per year worldwide. Currently, there are no effective drugs to prevent the growth or rupture of aortic aneurysms; surgical repair or endovascular repair is the only option for treating this condition. The pathogenic mechanisms and therapeutic targets for aortic aneurysms have been examined over the past decade; however, there are unknown pathogenic mechanisms involved in cellular heterogeneity and plasticity, the complexity of the transforming growth factor-beta signaling pathway, inflammation, cell death, intramural neovascularization, and intercellular communication. This review summarizes the latest research findings and current pathogenic mechanisms of aortic aneurysms, which may enhance our understanding of aortic aneurysms.
引用
下载
收藏
页码:2596 / 2607
页数:12
相关论文
共 50 条
  • [11] Understanding the pathogenesis of abdominal aortic aneurysms
    Kuivaniemi, Helena
    Ryer, Evan J.
    Elmore, James R.
    Tromp, Gerard
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2015, 13 (09) : 975 - 987
  • [12] Role of Noncoding RNAs in the Pathogenesis of Abdominal Aortic Aneurysm Possible Therapeutic Targets?
    Kumar, Sandeep
    Boon, Reinier A.
    Maegdefessel, Lars
    Dimmeler, Stefanie
    Jo, Hanjoong
    CIRCULATION RESEARCH, 2019, 124 (04) : 619 - 630
  • [13] Aortic Wall Inflammation in the Pathogenesis, Diagnosis and Treatment of Aortic Aneurysms
    Georgia Skotsimara
    Alexios Antonopoulos
    Evangelos Oikonomou
    Charalampos Papastamos
    Gerasimos Siasos
    Dimitrios Tousoulis
    Inflammation, 2022, 45 : 965 - 976
  • [14] Aortic Wall Inflammation in the Pathogenesis, Diagnosis and Treatment of Aortic Aneurysms
    Skotsimara, Georgia
    Antonopoulos, Alexios
    Oikonomou, Evangelos
    Papastamos, Charalampos
    Siasos, Gerasimos
    Tousoulis, Dimitrios
    INFLAMMATION, 2022, 45 (03) : 965 - 976
  • [15] PATHOGENESIS OF ACQUIRED ABDOMINAL AORTIC-ANEURYSMS
    ANIDJAR, S
    MICHEL, JB
    PRESSE MEDICALE, 1991, 20 (18): : 859 - 865
  • [16] Exploring autoimmunity in the pathogenesis of abdominal aortic aneurysms
    Chang, Tiffany W.
    Gracon, Adam S. A.
    Murphy, Michael P.
    Wilkes, David S.
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2015, 309 (05): : H719 - H727
  • [17] Aortic aneurysms - epidemiology and therapeutic options
    Mujagic, Edin
    Guerke, Lorenz
    THERAPEUTISCHE UMSCHAU, 2018, 75 (08) : 471 - 477
  • [18] Pharmacological targets in the treatment of abdominal aortic aneurysms
    Bergoeing, Michel P.
    Thompson, Robert W.
    Curci, John A.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2006, 10 (04) : 547 - 559
  • [19] The pathogenesis and potential therapeutic targets in sepsis
    Zhang, Wendan
    Jiang, Honghong
    Wu, Gaosong
    Huang, Pengli
    Wang, Haonan
    An, Huazhasng
    Liu, Sanhong
    Zhang, Weidong
    MEDCOMM, 2023, 4 (06):
  • [20] Mycobacterium tuberculosis: Pathogenesis and therapeutic targets
    Yang, Jiaxing
    Zhang, Laiying
    Qiao, Wenliang
    Luo, Youfu
    MEDCOMM, 2023, 4 (05):